Literature DB >> 28828750

Rocuronium bromide: clinical application of single-dose pharmacokinetic models to continuous infusion.

Yutaka Oda1.   

Abstract

Entities:  

Year:  2017        PMID： 28828750     DOI： 10.1007/s00540-017-2401-8

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  15 in total

1.  Continuous rocuronium administration for tracheomalacia.

Authors:  Takeshi Yano; Masahiko Taniguchi; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2015-07-30       Impact factor: 2.078

2.  Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol-remifentanil anesthesia.

Authors:  Takahiro Moriyama; Akira Matsunaga; Osamu Nagata; Kei Enohata; Tomomi Kamikawaji; Erika Uchino; Yuichi Kanmura
Journal:  J Anesth       Date:  2015-03-01       Impact factor: 2.078

3.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.

Authors:  J M Wierda; U W Kleef; L M Lambalk; W D Kloppenburg; S Agoston
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

4.  [Effects of sevoflurane and propofol on neuromuscular blocking action of Org 9426 (rocuronium bromide) infused continuously in Japanese patients].

Authors:  Syunichi Takagi; Makoto Ozaki; Hiroshi Iwasaki; Yoshio Hatano; Junzo Takeda
Journal:  Masui       Date:  2006-08

5.  Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia.

Authors:  E P McCoy; R K Mirakhur; V R Maddineni; J M Wierda; J H Proost
Journal:  Br J Anaesth       Date:  1996-01       Impact factor: 9.166

6.  Cumulation characteristics of cisatracurium and rocuronium during continuous infusion.

Authors:  D R Miller; C Wherrett; K Hull; J Watson; S Legault
Journal:  Can J Anaesth       Date:  2000-10       Impact factor: 5.063

7.  Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients.

Authors:  J A Alvarez-Gomez; M E Estelles; J Fabregat; F Perez; A J Brugger
Journal:  Eur J Anaesthesiol Suppl       Date:  1994

8.  Time course of action and recovery of rocuronium bromide in children during halothane anaesthesia--a preliminary report.

Authors:  J Motsch; M Leuwer; M Pfau; J Zimmerman; E Martin
Journal:  Eur J Anaesthesiol Suppl       Date:  1994

9.  Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.

Authors:  R A Cooper; V R Maddineni; R K Mirakhur; J M Wierda; M Brady; K T Fitzpatrick
Journal:  Br J Anaesth       Date:  1993-08       Impact factor: 9.166

10.  Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.

Authors:  Yoshifumi Kotake; Ryoichi Ochiai; Takahiro Suzuki; Setsuro Ogawa; Shunichi Takagi; Makoto Ozaki; Itsuo Nakatsuka; Junzo Takeda
Journal:  Anesth Analg       Date:  2013-06-11       Impact factor: 5.108
View more
  1 in total

1.  Reduction of the rocuronium-induced withdrawal reflex by MR13A10A, a generic rocuronium with a novel solution: A randomized, controlled study.

Authors:  Masaru Shimizu; Fumimasa Amaya; Mao Kinoshita; Masaki Yamasaki; Isao Yokota; Teiji Sawa
Journal:  PLoS One       Date:  2019-10-30       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.